CD36 and fatty liver disease: Administration of L. intestinalis reversed the impairment in glucose tolerance (Fig.4a) as well as increment in plasma triglyceride (Fig. 4b), lipid absorption (Fig. 4c), intestinal Cd36 (P = 0.0008) (Fig. 4d), liver steatosis measured by oil red O and H&E staining (Fig. 4e), and adiposity (Fig. 4f).